Flux Power Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Flux Power Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Jun 30, 2019 | $9.32M | Sep 12, 2019 |
| FY2019 | Jun 30, 2018 | $4.12M | Sep 12, 2019 |
| FY2018 | Jun 30, 2017 | $902.0K | Sep 27, 2018 |
| FY2015 | Jun 30, 2015 | $715.0K | Sep 28, 2015 |
| FY2015 | Jun 30, 2014 | $358.0K | Sep 28, 2015 |
| FY2014 | Jun 30, 2013 | $772.0K | Oct 7, 2014 |
| FY2013 | Jun 30, 2012 | $5.93M | Oct 15, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $66.43M | Sep 17, 2025 |
| FY2024 | Jun 30, 2024 | $13.38M | Jan 29, 2025 |
| FY2024 | Mar 31, 2024 | $14.46M | Jan 29, 2025 |
| FY2024 | Dec 31, 2023 | $18.20M | Jan 29, 2025 |
| FY2024 | Sep 30, 2023 | $14.79M | Jan 29, 2025 |
| FY2024 | Jun 30, 2023 | $16.40M | Jan 29, 2025 |
| FY2024 | Mar 31, 2023 | $15.09M | Jan 29, 2025 |
| FY2024 | Dec 31, 2022 | $17.16M | Jan 29, 2025 |
| FY2024 | Sep 30, 2022 | $17.84M | Jan 29, 2025 |
| FY2024 | Jun 30, 2022 | $15.20M | Jan 29, 2025 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $902.0K | Sep 22, 2017 |
| FY2017 | Jun 30, 2016 | $558.0K | Sep 22, 2017 |
| FY2016 | Jun 30, 2015 | $715.0K | Sep 26, 2016 |
| FY2015 | Jun 30, 2014 | $358.0K | Sep 28, 2015 |
| FY2014 | Jun 30, 2013 | $772.0K | Oct 7, 2014 |
| FY2013 | Jun 30, 2012 | $5.93M | Oct 15, 2013 |
| FY2012 | Jun 30, 2011 | $984.0K | Oct 29, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $21.74M | Sep 17, 2025 |
| FY2024 | Jun 30, 2024 | $3.59M | Jan 29, 2025 |
| FY2024 | Mar 31, 2024 | $4.03M | Jan 29, 2025 |
| FY2024 | Dec 31, 2023 | $5.38M | Jan 29, 2025 |
| FY2024 | Sep 30, 2023 | $4.24M | Jan 29, 2025 |
| FY2024 | Jun 30, 2023 | $3.60M | Jan 29, 2025 |
| FY2024 | Mar 31, 2023 | $4.68M | Jan 29, 2025 |
| FY2024 | Dec 31, 2022 | $3.99M | Jan 29, 2025 |
| FY2024 | Sep 30, 2022 | $3.62M | Jan 29, 2025 |
| FY2024 | Jun 30, 2022 | $2.71M | Jan 29, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($6.67M) | Sep 17, 2025 |
| FY2024 | Jun 30, 2024 | ($2.24M) | Jan 29, 2025 |
| FY2024 | Mar 31, 2024 | ($3.01M) | Jan 29, 2025 |
| FY2024 | Dec 31, 2023 | ($896.0K) | Jan 29, 2025 |
| FY2024 | Sep 30, 2023 | ($2.19M) | Jan 29, 2025 |
| FY2024 | Jun 30, 2023 | ($2.20M) | Jan 29, 2025 |
| FY2024 | Mar 31, 2023 | ($1.49M) | Jan 29, 2025 |
| FY2024 | Dec 31, 2022 | ($1.80M) | Jan 29, 2025 |
| FY2024 | Sep 30, 2022 | ($2.26M) | Jan 29, 2025 |
| FY2024 | Jun 30, 2022 | ($2.84M) | Jan 29, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($5.03M) | Sep 17, 2025 |
| FY2024 | Jun 30, 2024 | ($1.81M) | Jan 29, 2025 |
| FY2024 | Mar 31, 2024 | ($2.57M) | Jan 29, 2025 |
| FY2024 | Dec 31, 2023 | ($447.0K) | Jan 29, 2025 |
| FY2024 | Sep 30, 2023 | ($1.79M) | Jan 29, 2025 |
| FY2024 | Jun 30, 2023 | ($1.83M) | Jan 29, 2025 |
| FY2024 | Mar 31, 2023 | ($1.23M) | Jan 29, 2025 |
| FY2024 | Dec 31, 2022 | ($1.42M) | Jan 29, 2025 |
| FY2024 | Sep 30, 2022 | ($1.93M) | Jan 29, 2025 |
| FY2024 | Jun 30, 2022 | ($2.67M) | Jan 29, 2025 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $4.46M | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | $4.92M | Sep 17, 2025 |
| FY2024 | Mar 31, 2024 | $1.29M | Jan 29, 2025 |
| FY2024 | Dec 31, 2023 | $1.24M | Jan 29, 2025 |
| FY2024 | Sep 30, 2023 | $1.30M | Jan 29, 2025 |
| FY2024 | Jun 30, 2023 | $4.68M | Jan 29, 2025 |
| FY2024 | Mar 31, 2023 | $1.18M | Jan 29, 2025 |
| FY2024 | Dec 31, 2022 | $1.16M | Jan 29, 2025 |
| FY2024 | Sep 30, 2022 | $1.02M | Jan 29, 2025 |
| FY2024 | Jun 30, 2022 | $6.31M | Jan 29, 2025 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $22.30M | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | $18.93M | Sep 17, 2025 |
| FY2024 | Mar 31, 2024 | $5.31M | Jan 29, 2025 |
| FY2024 | Dec 31, 2023 | $4.59M | Jan 29, 2025 |
| FY2024 | Sep 30, 2023 | $4.73M | Jan 29, 2025 |
| FY2024 | Jun 30, 2023 | $17.62M | Jan 29, 2025 |
| FY2024 | Mar 31, 2023 | $4.72M | Jan 29, 2025 |
| FY2024 | Dec 31, 2022 | $4.25M | Jan 29, 2025 |
| FY2024 | Sep 30, 2022 | $4.54M | Jan 29, 2025 |
| FY2024 | Jun 30, 2022 | $15.52M | Jan 29, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $610.0K | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | ($4.80M) | Sep 17, 2025 |
| FY2024 | Mar 31, 2024 | ($4.27M) | Jan 29, 2025 |
| FY2024 | Dec 31, 2023 | ($4.05M) | Jan 29, 2025 |
| FY2024 | Sep 30, 2023 | ($3.09M) | Jan 29, 2025 |
| FY2024 | Jun 30, 2023 | ($3.57M) | Jan 29, 2025 |
| FY2024 | Mar 31, 2023 | ($5.20M) | Jan 29, 2025 |
| FY2024 | Dec 31, 2022 | ($1.89M) | Jan 29, 2025 |
| FY2024 | Sep 30, 2022 | ($589.0K) | Jan 29, 2025 |
| FY2024 | Jun 30, 2022 | ($23.89M) | Jan 29, 2025 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $653.0K | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | $853.0K | Sep 17, 2025 |
| FY2024 | Mar 31, 2024 | $588.0K | Jan 29, 2025 |
| FY2024 | Dec 31, 2023 | $338.0K | Jan 29, 2025 |
| FY2024 | Sep 30, 2023 | $181.0K | Jan 29, 2025 |
| FY2024 | Jun 30, 2023 | $1.03M | Jan 29, 2025 |
| FY2024 | Mar 31, 2023 | $753.0K | Jan 29, 2025 |
| FY2024 | Dec 31, 2022 | $344.0K | Jan 29, 2025 |
| FY2024 | Sep 30, 2022 | $352.0K | Jan 29, 2025 |
| FY2024 | Jun 30, 2022 | $797.0K | Jan 29, 2025 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $34.75M | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | $32.30M | Sep 17, 2025 |
| FY2024 | Mar 31, 2024 | $34.03M | Jan 29, 2025 |
| FY2024 | Dec 31, 2023 | $35.09M | Jan 29, 2025 |
| FY2024 | Sep 30, 2023 | $34.16M | Jan 29, 2025 |
| FY2024 | Jun 30, 2023 | $33.02M | Jan 29, 2025 |
| FY2024 | Mar 31, 2023 | $35.18M | Jan 29, 2025 |
| FY2024 | Dec 31, 2022 | $33.27M | Jan 29, 2025 |
| FY2024 | Sep 30, 2022 | $34.50M | Jan 29, 2025 |
| FY2024 | Jun 30, 2022 | $29.06M | Jan 29, 2025 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $40.16M | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | $32.11M | Sep 17, 2025 |
| FY2024 | Mar 31, 2024 | $31.97M | Jan 29, 2025 |
| FY2024 | Dec 31, 2023 | $30.69M | Jan 29, 2025 |
| FY2024 | Sep 30, 2023 | $29.35M | Jan 29, 2025 |
| FY2024 | Jun 30, 2023 | $26.30M | Jan 29, 2025 |
| FY2024 | Mar 31, 2023 | $27.38M | Jan 29, 2025 |
| FY2024 | Dec 31, 2022 | $24.91M | Jan 29, 2025 |
| FY2024 | Sep 30, 2022 | $24.56M | Jan 29, 2025 |
| FY2024 | Jun 30, 2022 | $16.95M | Jan 29, 2025 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($5.40M) | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | $194.0K | Sep 17, 2025 |
| FY2024 | Mar 31, 2024 | $2.07M | Jan 29, 2025 |
| FY2024 | Dec 31, 2023 | $4.40M | Jan 29, 2025 |
| FY2024 | Sep 30, 2023 | $4.81M | Jan 29, 2025 |
| FY2025 | Jun 30, 2023 | $6.72M | Sep 17, 2025 |
| FY2024 | Mar 31, 2023 | $7.81M | Jan 29, 2025 |
| FY2024 | Dec 31, 2022 | $8.36M | Jan 29, 2025 |
| FY2024 | Sep 30, 2022 | $9.95M | Jan 29, 2025 |
| FY2024 | Jun 30, 2022 | $12.11M | Jan 29, 2025 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($106.39M) | Sep 17, 2025 |
| FY2025 | Mar 31, 2025 | $4.37M | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | ($99.71M) | Sep 17, 2025 |
| FY2024 | Mar 31, 2024 | ($97.47M) | Jan 29, 2025 |
| FY2024 | Dec 31, 2023 | ($94.46M) | Jan 29, 2025 |
| FY2024 | Sep 30, 2023 | ($93.57M) | Jan 29, 2025 |
| FY2024 | Jun 30, 2023 | ($91.38M) | Jan 29, 2025 |
| FY2024 | Mar 31, 2023 | ($89.18M) | Jan 29, 2025 |
| FY2024 | Dec 31, 2022 | ($87.69M) | Jan 29, 2025 |
| FY2024 | Sep 30, 2022 | ($85.90M) | Jan 29, 2025 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.33M | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | $643.0K | Sep 17, 2025 |
| FY2024 | Mar 31, 2024 | $1.25M | Jan 29, 2025 |
| FY2024 | Dec 31, 2023 | $1.58M | Jan 29, 2025 |
| FY2024 | Sep 30, 2023 | $1.14M | Jan 29, 2025 |
| FY2024 | Jun 30, 2023 | $2.38M | Jan 29, 2025 |
| FY2024 | Mar 31, 2023 | $790.0K | Jan 29, 2025 |
| FY2024 | Dec 31, 2022 | $157.0K | Jan 29, 2025 |
| FY2024 | Sep 30, 2022 | $306.0K | Jan 29, 2025 |
| FY2024 | Jun 30, 2022 | $485.0K | Jan 29, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 17, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Jan 29, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Jan 29, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Jan 29, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Jan 29, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Jan 29, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Jan 29, 2025 |
| FY2024 | Dec 31, 2022 | 0 | Jan 29, 2025 |
| FY2024 | Sep 30, 2022 | 0 | Jan 29, 2025 |
| FY2024 | Jun 30, 2022 | 0 | Jan 29, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 17, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Jan 29, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Jan 29, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Jan 29, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Jan 29, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Jan 29, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Jan 29, 2025 |
| FY2024 | Dec 31, 2022 | 0 | Jan 29, 2025 |
| FY2024 | Sep 30, 2022 | 0 | Jan 29, 2025 |
| FY2024 | Jun 30, 2022 | 0 | Jan 29, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 16.84M | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | 16.68M | Sep 17, 2025 |
| FY2024 | Mar 31, 2024 | 16.60M | Jan 29, 2025 |
| FY2024 | Dec 31, 2023 | 16.53M | Jan 29, 2025 |
| FY2024 | Sep 30, 2023 | 16.48M | Jan 29, 2025 |
| FY2024 | Jun 30, 2023 | 16.46M | Jan 29, 2025 |
| FY2024 | Mar 31, 2023 | 16.16M | Jan 29, 2025 |
| FY2024 | Dec 31, 2022 | 16.03M | Jan 29, 2025 |
| FY2024 | Sep 30, 2022 | 16.00M | Jan 29, 2025 |
| FY2024 | Jun 30, 2022 | 16.00M | Jan 29, 2025 |